
SYNCOMFSyncom Formulations (India) Ltd.
Syncom Formulations (India) Q2 FY27 Results: Consolidated Net Profit ₹26.65 Crore on Total Income of ₹148 Crore
Syncom Formulations (India) reported consolidated total income of ₹148.21 crore and net profit of ₹26.65 crore for the quarter ended 30 Sep 2026, and standalone total income of ₹142.70 crore and net profit of ₹25.40 crore. The results were approved by the board on 13 Nov 2026, the company said in a filing on 13 Nov 2026.
- Earnings
- Pharmaceuticals